`
`
`
`
`
`
`
`
`
`Before the Patent Trial and Appeal Board
`
`AMERIGEN PHARMACEUTICALS LIMITED,
`
`Petitioner
`
`v.
`
`JANSSEN ONCOLOGY, INC.,
`
`Patent Owner
`
`
`
`
`
`
`
`
`
`
`
`
`U.S. Patent No. 8,822,438 to Auerbach et al.
`Issue Date: September 2, 2014
`Title: Methods and Compositions for Treating Cancer
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`Inter Partes Review No. Unassigned
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`Petition for Inter Partes Review of U.S. Patent No. 8,822,438 Under
`35 U.S.C. §§ 311-319 and 37 C.F.R. §§ 42.1-42.80, 42.100-42.123
`
`
`POWER OF ATTORNEY FOR AMERIGEN PHARMACEUTICALS, LTD.
`
`The undersigned duly authorized representative of Amerigen Pharmaceuticals,
`
`Ltd. hereby appoints the following practitioners as its representatives before the
`
`United States Patent and Trademark Office in connection with the Inter Partes
`
`Review of U.S. Patent No. 8,822,438:
`
`
`
`
`
`
`
`Lead Counsel
`
`Back-Up Counsel
`
`William Hare (Reg. No. 44,739)
`McNeely Hare & War LLP
`12 Roszel Road, Suite C104,
`Princeton, NJ 08540
`Telephone: (202) 640-1801
`Fax: (202) 478-1813
`bill@miplaw.com
`
`Gabriela Materassi (Reg. No. 47,774)
`McNeely Hare & War LLP
`12 Roszel Road, Suite C104,
`Princeton, NJ 08540
`Telephone: (347) 684-4154
`Fax: (202) 478-1813
`materassi@miplaw.com
`
`
`
`Respectfully submitted,
`
`
`
`/jonathan embleton/
`For: Amerigen Pharmaceuticals, Ltd.
`
`Name: Jonathan Embleton
`
`Title: Chief Business Officer
`
`Date: December 4, 2015